Aspect Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$102K Sell
699
-4
-0.6% -$553 0.04% 113
2026
Q2
$90.3K Hold
703
– – 0.03% 117
2026
Q1
$84.6K Hold
703
– – 0.03% 114
2025
Q4
$74K Hold
703
– – 0.03% 120
2025
Q3
$59K Sell
703
-110
-14% -$9.06K 0.03% 145
2025
Q2
$64.4K Buy
813
+113
+16% +$8.98K 0.03% 139
2025
Q1
$62.8K Sell
700
-25
-3% -$2.33K 0.04% 118
2024
Q4
$72.1K Sell
725
-43
-6% -$4.43K 0.04% 113
2024
Q3
$87.2K Buy
768
+54
+8% +$6.42K 0.05% 99
2024
Q2
$88.4K Hold
714
– – 0.05% 94
2024
Q1
$94.2K Hold
714
– – 0.07% 93
2023
Q4
$77.8K Buy
+714
New +$74.1K 0.05% 97

Other funds holding MRK

Aspect Partners's MRK Position: Q3 2026 in Review

Aspect Partners reduced its Merck (MRK) stake by 0.57% in Q3 2026, selling an estimated $553 and leaving 699 shares worth $102K. The position accounts for 0.04% of the portfolio, ranked #113.

Aspect Partners first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. 1,172 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Aspect Partners held 699 shares of Merck worth $102K as of Q3 2026.
  • Aspect Partners sold 4 Merck shares in Q3 2026, an estimated $553.
  • Merck made up 0.04% of Aspect Partners's portfolio in Q3 2026, its #113 holding.
  • Aspect Partners first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • 1,172 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.